J. B. Chemicals & Pharmaceuticals Limited
Символ: JBCHEPHARM.NS
NSE
1865.05
INRПазарна цена днес
56.2469
Съотношение P/E
8.9314
Коефициент PEG
289.45B
MRK Cap
- 0.01%
Доходност на DIV
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 14014.14 | 2928.6 | 566.5 | 6936.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 18953.58 | 2159.3 | 1.1 | 6649.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 12931.3 | 5771.7 | 6238.8 | 4186.7 | ||||||||||||||||||
balance-sheet.row.inventory | 8550.2 | 4304.9 | 4099.6 | 3474.5 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 3989.1 | 2275.1 | 1843.6 | 928.2 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 39484.74 | 15280.3 | 12748.5 | 15526 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 12134.4 | 5764.2 | 5668.2 | 5696.6 | ||||||||||||||||||
balance-sheet.row.goodwill | 1149.2 | 574.6 | 574.6 | 574.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 26174.6 | 13222.8 | 6713.9 | 321.1 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 27323.8 | 13797.4 | 7288.5 | 895.6 | ||||||||||||||||||
balance-sheet.row.long-term-investments | -3160.56 | 137.8 | 127.2 | 129.1 | ||||||||||||||||||
balance-sheet.row.tax-assets | 119.1 | 65.1 | 64.3 | 69.4 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | -2370.78 | 493.9 | 177.2 | 64.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 34045.96 | 20258.4 | 13325.5 | 6855.1 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 73530.7 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 5610.5 | 2386.4 | 2244.8 | 1869.2 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 3319.8 | 1739.1 | 339.4 | 398.5 | ||||||||||||||||||
balance-sheet.row.tax-payables | 245.2 | 49.5 | 60.9 | 79 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 6908.4 | 3985.4 | 206.2 | 51.4 | ||||||||||||||||||
Deferred Revenue Non Current | 330.1 | 152.1 | 31.7 | 49.3 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 2302.2 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 419.8 | 236.5 | 88.2 | 99.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9588.4 | 5190.7 | 850.7 | 794.1 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 474.8 | 242.1 | 282.4 | 123.4 | ||||||||||||||||||
balance-sheet.row.total-liab | 21560.1 | 10735.2 | 4687.9 | 4246.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 309.8 | 154.8 | 154.6 | 154.6 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 22757.07 | 22757.1 | 18427.1 | 15847.9 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 81681.48 | 2698.8 | 2248.4 | 1583.6 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -807.13 | -807.1 | 511.2 | 511.2 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 103941.22 | 24803.5 | 21341.2 | 18097.2 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 125501.32 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 44.9 | 37.1 | ||||||||||||||||||
balance-sheet.row.total-equity | 103941.22 | 24803.5 | 21386.1 | 18134.3 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 125501.32 | - | - | - | ||||||||||||||||||
Total Investments | 13819.78 | 323.9 | 128.1 | 130.9 | ||||||||||||||||||
balance-sheet.row.total-debt | 10228.2 | 5724.5 | 545.6 | 449.9 | ||||||||||||||||||
balance-sheet.row.net-debt | 15167.64 | 4955.2 | -19.9 | 163 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 5141.06 | 5552.3 | 5049 | 5968.9 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 1293.8 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1146.7 | -1685.9 | 0 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 361.93 | 693.7 | 626.5 | 0 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -299.2 | -3025.2 | -942.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | -417.5 | -2928.4 | -706 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -205.2 | -625.1 | -700.9 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | 323.5 | 528.3 | 464.8 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | -5502.99 | 311.9 | 10.3 | -2565.6 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 2194.93 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1998.6 | -7003.9 | -85 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -7568.7 | -5084.7 | -5412.1 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 5570.1 | 12088.6 | 3169.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -1968.4 | 7091.1 | 498.9 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9617.9 | 23.2 | -2306.8 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -872.5 | -3.3 | -3.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 84.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 5684.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -1275.9 | -1275.6 | -732.4 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -55.8 | -105 | -138.6 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3565.4 | -1383.9 | -874.2 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.3 | 0 | 0.4 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 2194.93 | 203.9 | 340.7 | -32.8 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4748.46 | 769.3 | 565.4 | 224.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2553.52 | 565.4 | 224.7 | 257.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 2194.93 | 6256.1 | 1701.3 | 3147.8 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 2194.93 | -1393.4 | -5366.5 | 2670.1 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 33847.7 | 31492.8 | 24242.4 | 20058.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 3726.5 | 3842.2 | 8633.7 | 7174.4 | ||||||||||||||||||
income-statement-row.row.gross-profit | 30121.2 | 27650.6 | 15608.7 | 12884.1 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 319.33 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 74.12 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1807.78 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 252.2 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 14951.1 | 13997.4 | 10862.7 | 8009.7 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 4680.2 | 3842.2 | 19496.5 | 15184.1 | ||||||||||||||||||
income-statement-row.row.interest-income | 325.69 | 25.4 | 9.3 | 17.7 | ||||||||||||||||||
income-statement-row.row.interest-expense | 488.8 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1807.78 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 246 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 252.2 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 246 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.interest-expense | 488.8 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1293.8 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 30296.1 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 28946 | 5917.9 | 4739 | 4895.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 29192 | 27650.6 | 5049 | 5968.9 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 1393.5 | 893.1 | 1188.6 | 1483.6 | ||||||||||||||||||
income-statement-row.row.net-income | 5141 | 4098.3 | 3853.6 | 4479.6 |
Често задавани въпроси
Какво е J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) общи активи?
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) общите активи са 35538700000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 17262500000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 14.157.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 14.157.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.152.
Какъв е общият приход на предприятието?
Общият приход е 0.855.
Каква е J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 4098300000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 5724500000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 13997400000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са -3932900001.000.